- AU$245.00m
- AU$370.36m
- AU$209.59m
- 85
- 66
- 95
- 94
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 17.13 | ||
| PEG Ratio (f) | 0.56 | ||
| EPS Growth (f) | 43.8% | ||
| Dividend Yield (f) | 4.35% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.83 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 21.01 | ||
| Price to Sales | 1.07 | ||
| EV to EBITDA | 16.47 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.52% | ||
| Return on Equity | 4.51% | ||
| Operating Margin | -1.83% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 149.24 | 153.79 | 178 | 184.16 | 209.59 | 238.49 | 252.89 | 11.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +503.29 | -70.51 | +229.82 | -1.04 | -81.24 | +374.14 | +27.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Capitol Health Limited is an Australia-based company that is principally engaged in the provision of diagnostic imaging services. The Company operates through diagnostic imaging facilities in Australia. The Company operates approximately 63 clinics throughout Victoria, Tasmania, Western Australia, and South Australia. Its businesses operate under the brands Capital Radiology, Imaging at Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Women’s Imaging, and Direct Radiology. The Company manages the needs of patients requiring diagnostic imaging and interventional services, including general X-rays, ultrasounds, computed tomography (CT) and magnetic resonance imaging (MRI), and specialized services, such as mammography, echocardiography, nuclear medicine, cardiac imaging, and specialty musculoskeletal procedures.
Directors
- Andrew Demetriou NEC
- Justin Walter CEO
- Craig Bremner CFO
- Greg Hughes COO
- Melanie Leydin SEC
- Richard Loveridge NID
- Laura McBain NID
- Kevin Shaw NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 1st, 2005
- Public Since
- June 9th, 2006
- No. of Shareholders
- 5,409
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 1,065,199,089
- Address
- Level 2, MELBOURNE, 3002
- Web
- https://www.capitolhealth.com.au/
- Phone
- +61 393483333
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for CAJ
Similar to CAJ
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
What is the Capitol Health share price?
As of Today at 19:04 UTC, shares in Capitol Health are trading at AU$0.23. This share price information is delayed by 15 minutes.
How has the Capitol Health share price performed this year?
Shares in Capitol Health last closed at AU$0.23 and the price had moved by -17.86% over the past 365 days. In terms of relative price strength the Capitol Health share price has underperformed the ASX All Ordinaries Index by -21.43% over the past year.
What are the analyst and broker recommendations for Capitol Health?
The overall consensus recommendation for Capitol Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Capitol Health dividend yield?
The Capitol Health dividend yield is 4.35% based on the trailing twelve month period.
Does Capitol Health pay a dividend?
Last year, Capitol Health paid a total dividend of AU$0.01, and it currently has a trailing dividend yield of 4.35%. We do not have any data on when Capitol Health is to next pay dividends.
When does Capitol Health next pay dividends?
We do not have data on when Capitol Health is to next pay dividends. The historic dividend yield on Capitol Health shares is currently 4.35%.
How do I buy Capitol Health shares?
To buy shares in Capitol Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Capitol Health?
As of the previous close price of AU$0.23, shares in Capitol Health had a market capitalisation of AU$245.00m.
Where are Capitol Health shares listed?
Here are the trading details for Capitol Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CAJ
What kind of share is Capitol Health?
Based on an overall assessment of its quality, value and momentum Capitol Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Capitol Health share price forecast for 2024?
The analyst consensus target price for shares in Capitol Health is AU$0.28. That is 23.48% above the last closing price of AU$0.23.
Analysts covering Capitol Health currently have a consensus Earnings Per Share (EPS) forecast of AU$0.01 for the next financial year.
What is the trend in the Capitol Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Capitol Health. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +4.97%.
As of the last closing price of AU$0.23, shares in Capitol Health were trading +0.03% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Capitol Health PE Ratio?
The Capitol Health PE ratio based on its reported earnings over the past 12 months is 17.13. The shares last closed at AU$0.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Capitol Health?
Capitol Health's management team is headed by:
- Andrew Demetriou - NEC
- Justin Walter - CEO
- Craig Bremner - CFO
- Greg Hughes - COO
- Melanie Leydin - SEC
- Richard Loveridge - NID
- Laura McBain - NID
- Kevin Shaw - NID